Jordana K Schmier

Summary

Affiliation: Exponent Inc
Country: USA

Publications

  1. ncbi request reprint Evaluation of Medicare costs of endophthalmitis among patients after cataract surgery
    Jordana K Schmier
    Exponent, Inc, Alexandria, Virginia 22314, USA
    Ophthalmology 114:1094-9. 2007
  2. ncbi request reprint The burden of age-related macular degeneration
    Jordana K Schmier
    Exponent, Alexandria, Virginia, USA
    Pharmacoeconomics 24:319-34. 2006
  3. ncbi request reprint The economic implications of glaucoma: a literature review
    Jordana K Schmier
    Exponent, Alexandria, Virginia 22314, USA
    Pharmacoeconomics 25:287-308. 2007
  4. doi request reprint Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma
    Jordana K Schmier
    Exponent Inc, Alexandria, VA 22314, USA
    Clin Drug Investig 32:835-42. 2012
  5. doi request reprint Patterns and costs associated with progression of age-related macular degeneration
    Jordana K Schmier
    Exponent, Inc, Alexandria, Virginia, USA
    Am J Ophthalmol 154:675-681.e1. 2012
  6. ncbi request reprint The impact of inadequately controlled asthma in urban children on quality of life and productivity
    Jordana K Schmier
    Exponent, Alexandria, Virginia 22314, USA
    Ann Allergy Asthma Immunol 98:245-51. 2007
  7. ncbi request reprint Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression
    Jordana K Schmier
    Exponent Inc, Alexandria, VA 22314, USA
    Curr Med Res Opin 22:1737-43. 2006
  8. ncbi request reprint Impact of visual impairment on service and device use by individuals with age-related macular degeneration (AMD)
    Jordana K Schmier
    Exponent Inc, Alexandria, Virginia 22314, USA
    Disabil Rehabil 28:1331-7. 2006
  9. doi request reprint Medicare expenditures associated with diabetes and diabetic retinopathy
    Jordana K Schmier
    Exponent, Inc, Alexandria, Virginia, USA
    Retina 29:199-206. 2009
  10. ncbi request reprint Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration
    Jordana K Schmier
    Exponent Inc, Alexandria, VA, USA
    Retina 26:1056-62. 2006

Detail Information

Publications40

  1. ncbi request reprint Evaluation of Medicare costs of endophthalmitis among patients after cataract surgery
    Jordana K Schmier
    Exponent, Inc, Alexandria, Virginia 22314, USA
    Ophthalmology 114:1094-9. 2007
    ..However, little is known about the cost of treatment. The objective of this study was to estimate the direct medical cost of treatment for endophthalmitis in the United States...
  2. ncbi request reprint The burden of age-related macular degeneration
    Jordana K Schmier
    Exponent, Alexandria, Virginia, USA
    Pharmacoeconomics 24:319-34. 2006
    ..Further research is needed to integrate the information on various components of AMD-related costs into a comprehensive burden of illness estimate and to evaluate basic utility assumptions in existing models...
  3. ncbi request reprint The economic implications of glaucoma: a literature review
    Jordana K Schmier
    Exponent, Alexandria, Virginia 22314, USA
    Pharmacoeconomics 25:287-308. 2007
    ..As new screening technologies for early detection of individuals at elevated risk of glaucoma are now in use, more complete estimates of the cost of glaucoma are critical for issues of resource allocation and health policy...
  4. doi request reprint Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma
    Jordana K Schmier
    Exponent Inc, Alexandria, VA 22314, USA
    Clin Drug Investig 32:835-42. 2012
    ..Topical β-blockers are commonly prescribed for primary open-angle glaucoma. Existing research is limited regarding respiratory or cardiovascular events that may result from using these topical β-blockers...
  5. doi request reprint Patterns and costs associated with progression of age-related macular degeneration
    Jordana K Schmier
    Exponent, Inc, Alexandria, Virginia, USA
    Am J Ophthalmol 154:675-681.e1. 2012
    ..To evaluate patterns of disease progression among individuals with age-related macular degeneration (AMD) and to compare costs over time...
  6. ncbi request reprint The impact of inadequately controlled asthma in urban children on quality of life and productivity
    Jordana K Schmier
    Exponent, Alexandria, Virginia 22314, USA
    Ann Allergy Asthma Immunol 98:245-51. 2007
    ..The burden of inadequately controlled pediatric asthma on education and other daily activities is not well described...
  7. ncbi request reprint Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression
    Jordana K Schmier
    Exponent Inc, Alexandria, VA 22314, USA
    Curr Med Res Opin 22:1737-43. 2006
    ..In addition, visual functioning is known to affect medical costs. The objective of this study was to project visual field deficit progression and subsequent costs based on clinical trial data...
  8. ncbi request reprint Impact of visual impairment on service and device use by individuals with age-related macular degeneration (AMD)
    Jordana K Schmier
    Exponent Inc, Alexandria, Virginia 22314, USA
    Disabil Rehabil 28:1331-7. 2006
    ..To assess the patient-reported use of services, supplements, and devices among individuals with age-related macular degeneration (AMD) and evaluate the impact of visual impairment level on this use...
  9. doi request reprint Medicare expenditures associated with diabetes and diabetic retinopathy
    Jordana K Schmier
    Exponent, Inc, Alexandria, Virginia, USA
    Retina 29:199-206. 2009
    ..To estimate the expenditures for diabetic retinopathy in the United States by Medicare...
  10. ncbi request reprint Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration
    Jordana K Schmier
    Exponent Inc, Alexandria, VA, USA
    Retina 26:1056-62. 2006
    ..To assess the patient-reported use of caregiving among individuals with age-related macular degeneration (AMD) and evaluate the impact of visual impairment level on this use...
  11. ncbi request reprint Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective
    Jordana K Schmier
    Exponent Inc, Alexandria, VA 22314, USA
    Curr Med Res Opin 23:2867-75. 2007
    ..To evaluate costs associated with prostaglandin analogs among newly-diagnosed glaucoma patients in a managed-care population...
  12. ncbi request reprint Evaluation of costs for cystoid macular edema among patients after cataract surgery
    Jordana K Schmier
    Exponent Inc, 1800 Diagonal Road, Alexandria, VA 22314, USA
    Retina 27:621-8. 2007
    ..Little is known about the costs of cystoid macular edema (CME), an important complication associated with cataract surgery. The purpose of this analysis was to estimate the cost of treatment for CME in the United States...
  13. doi request reprint Impact of visual impairment on service and device use by individuals with diabetic retinopathy
    Jordana K Schmier
    Exponent, Alexandria, VA, USA
    Disabil Rehabil 31:659-65. 2009
    ..This study was performed to assess the use of devices and caregiving among individuals with diabetic retinopathy and to evaluate the impact of visual acuity on use...
  14. ncbi request reprint Validation of the Daily Living Tasks Dependent on Vision (DLTV) questionnaire in a U.S. population with age-related macular degeneration
    Jordana K Schmier
    Exponent, Inc, Alexandria, VA 22314, USA
    Ophthalmic Epidemiol 13:137-43. 2006
    ..This study evaluated the psychometric properties of the DLTV using patient-reported rates of use of services and devices in an outpatient population...
  15. doi request reprint First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008
    Jordana K Schmier
    Managing Scientist, Exponent Inc, Alexandria, VA, USA
    Curr Med Res Opin 26:2769-77. 2010
    ..The objective of this analysis was to estimate first-year treatment costs among new initiators of topical prostaglandin analogs in a managed care population...
  16. doi request reprint Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006
    Jordana K Schmier
    Exponent, Inc, 1800 Diagonal Rd, Ste 300, Alexandria, VA 22314, USA
    Arch Ophthalmol 127:900-5. 2009
    ..To identify payments and changes in payments for glaucoma surgical procedures among Medicare beneficiaries in the United States and to evaluate trends in costs based on the types of procedures being performed...
  17. doi request reprint The impact of climate change and aeroallergens on children's health
    Jordana K Schmier
    Exponent, Inc, Alexandria, Virginia 22314, USA
    Allergy Asthma Proc 30:229-37. 2009
    ..Strategies to reduce the impacts should be developed and implemented now...
  18. pmc Single food focus dietary guidance: lessons learned from an economic analysis of egg consumption
    Jordana K Schmier
    Exponent, 1800 Diagonal Road, Suite 300, Alexandria, VA 22314, USA
    Cost Eff Resour Alloc 7:7. 2009
    ..As newer data become available, the model should be updated...
  19. ncbi request reprint First-year treatment patterns among new initiators of topical prostaglandin analogs
    Jordana K Schmier
    Exponent Inc, 1800 Diagonal Road, Alexandria, VA 22314, USA
    Curr Med Res Opin 25:851-8. 2009
    ..To evaluate treatment patterns and costs among new initiators of topical prostaglandin analogs in a managed-care population...
  20. ncbi request reprint Practical applications of usability theory to electronic data collection for clinical trials
    Jordana K Schmier
    Exponent, 1800 Diagonal Road, Suite 300, Alexandria, VA 22314, United States
    Contemp Clin Trials 26:376-85. 2005
    ..Lessons learned from usability testing in the unique setting of the clinical trial can be applied to other projects to decrease costs, enhance the quality of the data, and minimize time to analysis...
  21. ncbi request reprint Cost of obesity in the workplace
    Jordana K Schmier
    Exponent Inc, Alexandria, Virginia, USA
    Scand J Work Environ Health 32:5-11. 2006
    ..Obesity is an important driver of costs in the workplace. These findings quantify the costs and can help employers consider whether to introduce workplace interventions or provide coverage for weight loss programs...
  22. ncbi request reprint Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence
    Jordana K Schmier
    Exponent Inc, Alexandria, Virginia 22314, USA
    Drugs Aging 22:717-29. 2005
    ....
  23. ncbi request reprint Resource utilization and costs of age-related macular degeneration
    Michael T Halpern
    Exponent Inc, Alexandria, VA 22314, USA
    Health Care Financ Rev 27:37-47. 2006
    ..Costs among patients with wet disease increased yearly at rates exceeding inflation, possibly due in part to increased rates of treatment with photodynamic therapy among these individuals and the aging of the population...
  24. ncbi request reprint Impacts of a smoking cessation benefit among employed populations
    Michael T Halpern
    Exponent, Alexandria, Virginia, USA
    J Occup Environ Med 49:11-21. 2007
    ..The objective of this study was to project the health and economic impacts of providing a workplace smoking cessation benefit...
  25. ncbi request reprint Costs and outcomes of extended-release vs. immediate-release clarithromycin for lower respiratory tract infections
    Michael T Halpern
    Exponent, Health Sciences Group, 1800 Diagonal Road, Suite 300, Alexandria, VA 22314, USA
    COPD 2:217-23. 2005
    ..Results indicate that clarithromycin extended-release is cost-saving compared with immediate-release for LRTI...
  26. ncbi request reprint The quality of life impact of acute exacerbations of chronic bronchitis (AECB): a literature review
    Jordana K Schmier
    Exponent, Alexandria, VA 22314, USA
    Qual Life Res 14:329-47. 2005
    ..Health-related quality of life (HRQL) is impaired in patients with COPD, but little is known about the direct effect of exacerbations on HRQL...
  27. ncbi request reprint Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity
    Michael T Halpern
    Exponent Inc, Alexandria, Virginia, USA
    J Asthma 41:117-26. 2004
    ..Physicians should assess asthma patients for symptoms of allergic rhinitis to improve asthma treatment...
  28. ncbi request reprint The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: a literature review
    Michael T Halpern
    Exponent Inc, Alexandria, VA 22314, USA
    J Manag Care Pharm 9:353-9. 2003
    ..Medical resource use associated with AECB can have a substantial economic impact on the patients, health care system, and society overall...
  29. ncbi request reprint The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events
    Jordana K Schmier
    Exponent, Alexandria, VA 22314, USA
    Manag Care 15:43-50. 2006
    ..To project the clinical and economic benefits of omega-3 supplements for prevention of secondary (repeat) cardiovascular events in U.S. males...
  30. ncbi request reprint Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis
    Michael T Halpern
    Exponent, Alexandria, Virginia, USA
    Ann Allergy Asthma Immunol 92:201-7; quiz 207-8, 267. 2004
    ..The impact of long-term inhaled corticosteroid (ICS) therapy on bone mineral density (BMD) is poorly understood...
  31. pmc First-year treatment costs among new initiators of topical prostaglandin analogs
    Jordana K Schmier
    Exponent Inc, Alexandria, VA, USA
    Clin Ophthalmol 3:637-44. 2009
    ..To estimate first-year costs among new initiators of topical prostaglandin analogs in a managed care population...
  32. ncbi request reprint Meta-analysis of bacterial resistance to macrolides
    Michael T Halpern
    Exponent, Inc, 1800 Diagonal Road, Suite 300, Alexandria, VA 22314, USA
    J Antimicrob Chemother 55:748-57. 2005
    ..This meta-analysis systematically evaluated resistance of Streptococcus pneumoniae and Streptococcus pyogenes to macrolide antibiotics among patients with community-acquired respiratory tract infections...
  33. pmc Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
    Jordana K Schmier
    Exponent, Alexandria, VI, USA
    Clin Ophthalmol 4:1137-43. 2010
    ..To determine treatment patterns and costs over a two-year period among new initiators of topical prostaglandin analogs in a managed care population by retrospective cohort analysis of an insurance claims database...
  34. doi request reprint Economic burden of periprosthetic joint infection in the United States
    Steven M Kurtz
    Exponent, Inc, Philadelphia, Pennsylvania Drexel University, Philadelphia, Pennsylvania, USA
    J Arthroplasty 27:61-5.e1. 2012
    ..62 billion by 2020. As the demand for joint arthroplasty is expected to increase substantially over the coming decade, so too will the economic burden of prosthetic infections...
  35. doi request reprint Mortality, cost, and health outcomes of total knee arthroplasty in medicare patients
    Scott T Lovald
    Exponent, Inc, Menlo Park, California
    J Arthroplasty 28:449-54. 2013
    ..9% at 7years (HR=0.93, P<0.001). The results demonstrate the patients in the TKA cohort as having a lower probability of heart failure and mortality, at a total incremental cost of $19,843...
  36. pmc First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results
    Jordana K Schmier
    Managing Scientist, Exponent Inc, Alexandria, VA, USA
    Clin Ophthalmol 4:437-45. 2010
    ..To estimate first-year treatment costs among new initiators of topical prostaglandin analogs in a managed care population...
  37. pmc Characteristics of respondents with glaucoma and dry eye in a national panel survey
    Jordana K Schmier
    Exponent Inc, Alexandria, VA, USA
    Clin Ophthalmol 3:645-50. 2009
    ..There is an increasing body of evidence strongly suggesting that glaucoma medications may contribute to ocular surface disease and development of dry eye...
  38. ncbi request reprint A stitch in time: improving public health early warning systems for extreme weather events
    Kristie L Ebi
    Exponent, Inc, Alexandria, VA 22314, USA
    Epidemiol Rev 27:115-21. 2005
  39. ncbi request reprint The cost effectiveness of varenicline for smoking cessation
    Michael T Halpern
    Department of Health Policy and Management, Emory University, Atlanta, Georgia 30322, USA
    Manag Care Interface 20:18-25. 2007
    ..Employers often experience additional savings from decreased absenteeism and increased productivity, with combined savings in health care plus workplace costs associated with varenicline use of $165 to $457 per smoker over two years...
  40. ncbi request reprint Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States
    Cynthia S Palmer
    MEDTAP International, Bethesda, Maryland, USA
    Pharmacoeconomics 20:617-28. 2002
    ....